Prior studies with BVA-100 have shown that blood volume measurement is crucial for treating heart failure, critical care patients in intensive care units, and in diagnosing the true status of complex anemias and syncope.
Daxor president Joseph Feldshuh said the aim of the company is to make the blood volume analyzer a standard of care in the treatment of critical conditions such as heart failure and intensive care unit medicine.
The Mayo Clinic in Arizona is a five-story, 240-exam room outpatient clinic offering outpatient surgery, laboratory, diagnostic testing, imaging and pharmacy services.
Daxor manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor’s single use diagnostic kit.
